The celecoxib derivative kinase inhibitor AR-12 (OSU-03012) inhibits Zika virus via down-regulation of the PI3K/Akt pathway and protects Zika virus-infected A129 mice: A host-targeting treatment strategy

Authors:

Abstract
No abstract available
Funding Information
  • Chow Sin Lan Charity Fund Limited
  • Chan Yin Chuen Memorial Charitable Foundation
  • Hong Kong Hainan Commercial Association South China Microbiology Research Fund
  • High Level Hospital-Summit Program
  • Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases
  • Ministry of Education of China
  • European Union's Horizon 2020 (653316)

This publication has 48 references indexed in Scilit: